Chairman of Boule Diagnostics resigns
Boule Diagnostics signs agreement to sell clinical chemistry systems in USA
Boule Diagnostics signs an exclusive distribution agreement for CRP diagnostics on the US market
Three new shareholders in Boule Diagnostics
Boule Diagnostics Interim report January-September 2015
Interim report January–June 2015
Interim report January – March 2015
Boule Diagnostics announces new financial objectives
Year-end report 2014
Boule Diagnostics wins strategic instruments procurement
Cision will store the added information in order to continuously be able to send you the information you’ve chosen to subscribe to. Read more about how Cision process personal data.
Search
Search on the page